[Clinical studies of cefaclor for respiratory tract infections].
Cefaclor (CCL) was administered to 27 patients with acute pneumonia and the following results were obtained. CCL was given 500 mg t. i. d. for 6 to 23 days. The clinical effects of CCL were excellent in 2 cases, good in 14 cases, fair in 6 cases and poor in 5 cases, the efficacy rate was 59.3%. No adverse reaction was observed. We conclude that CCL is considerably useful in the treatment of acute pneumonia of outpatients.
D000208:Acute Disease; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D002433:Cefaclor / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002506:Cephalexin / Q000031:analogs & derivatives*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000188:drug therapy*
D002433:Cefaclor; D002506:Cephalexin